1. Cell-free DNA does not vary significantly as a function of the activity of immunologically quiescent cardiac transplant recipients, despite the metabolic de…

Heart FailureTransplant; Failure, Heart

~Estimated

~$10 – $1,125

Baylor Research InstituteNCT04656080

Nationwide Hepatitis C NAT+ Cardiac Transplant Experience

In this study we seek to test the hypothesis that safety and clinical outcomes after cardiac transplantation utilizing HCV NAT+ donor organs as currently perfo…

Transplant; Failure, HeartHepatitis C

~Estimated

~$10 – $1,125

Baylor Research InstituteNCT04493385

Observational

PRESERVE CAP: A Prospective, Multi-Center, Single-Arm, Open-Label Study of Hearts Transplanted After Non-Ischemic Heart Preservation From Extended Donors Continued Access Protocol

The purpose of this study is to evaluate if Non-Ischemic Heart Preservation (NIHP) of extended criteria donor hearts using the XVIVO Heart Preservation System …

Heart TransplantHeart FailureTransplant; Failure, Heart

~Estimated

~$10 – $7,500

XVIVO PerfusionNCT06895070